V.M. Paralkar
Pfizer Global Research and Development
Groton Laboratories
CT 06340
USA
Name/email consistency: high
- An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Paralkar, V.M., Borovecki, F., Ke, H.Z., Cameron, K.O., Lefker, B., Grasser, W.A., Owen, T.A., Li, M., DaSilva-Jardine, P., Zhou, M., Dunn, R.L., Dumont, F., Korsmeyer, R., Krasney, P., Brown, T.A., Plowchalk, D., Vukicevic, S., Thompson, D.D. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2). Paralkar, V.M., Grasser, W.A., Mansolf, A.L., Baumann, A.P., Owen, T.A., Smock, S.L., Martinovic, S., Borovecki, F., Vukicevic, S., Ke, H.Z., Thompson, D.D. J. Cell. Physiol. (2002)
- Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. Paralkar, V.M., Vail, A.L., Grasser, W.A., Brown, T.A., Xu, H., Vukicevic, S., Ke, H.Z., Qi, H., Owen, T.A., Thompson, D.D. J. Biol. Chem. (1998)